ATAI | Investor Presentation Deck | 41 slides

atai Life Sciences · 2022-10

arc beats above · slides in the middle · loops below · scroll → 2 LOOPS

Deck intelligence map

coverage by narrative range · generated from this deck JSON

Narrative range 73 total

Metadata

Components

Metrics

Tools

Frameworks

Beats

Loops

Problem 1 slides 100% 1/1 slides 100% 1/1 slides · 14 hits

— 0/1 slides

100% 1/1 slides 100% 1/1 slides 100% 1/1 slides · 2 hits 100% 1/1 slides Agitation 3 slides 100% 3/3 slides 100% 3/3 slides · 22 hits

— 0/3 slides

33.3% 1/3 slides 100% 3/3 slides 100% 3/3 slides · 6 hits 100% 3/3 slides Solution 36 slides 100% 36/36 slides 100% 36/36 slides · 163 hits

— 0/36 slides

22.2% 8/36 slides 30.6% 11/36 slides 100% 36/36 slides · 69 hits 91.7% 33/36 slides Situation & Context 2 slides 100% 2/2 slides 100% 2/2 slides · 5 hits

— 0/2 slides

50% 1/2 slides

— 0/2 slides

100% 2/2 slides

— 0/2 slides

Evidence & Proof 31 slides 100% 31/31 slides 100% 31/31 slides · 142 hits

— 0/31 slides

25.8% 8/31 slides 29% 9/31 slides 100% 31/31 slides · 62 hits 100% 31/31 slides

Slide inventory

every slide · same image gating as the playbook

Corporate mission statement slide.front_matter

Open slide detail

front_matter

Open slide detail

transition

Open slide detailBeat · Situation & Context

Includes a specific date reference at the bottom: October 25, 2022.other

Open slide detailBeat · Situation & Context

Uses a two-column layout to contrast 'Significant Burden' with 'Urgent Need for Innovation'.frame_problem

Open slide detailBeat · ProblemLoop · Cost Of Inaction

The slide uses a Gantt-style visualization to represent clinical trial progress for various drug candidates.present_solution

Open slide detailBeat · AgitationLoop · Cost Of Inaction

The slide uses a horizontal arrow timeline to organize clinical trial phases and results.plan_implementation

Open slide detailBeat · AgitationLoop · Cost Of Inaction

Slide 08 in a presentation deck.introduce_nominees

Open slide detailBeat · Solution

front_matter

Open slide detailBeat · Solution

present_solution

Open slide detailBeat · SolutionLoop · Jobs To Be Done

The slide uses chemical structure diagrams to illustrate the relationship between the racemate and its enantiomers.present_solution

Open slide detailBeat · SolutionLoop · Jobs To Be Done

Data source: Zanos et al., 2016. The charts show dose-dependent reduction in immobility time.analyze_data

Open slide detailBeat · SolutionLoop · Jobs To Be Done

The slide uses a third-party study (Yang et al., 2015) to support the claim of a superior therapeutic index for R-ketamine.analyze_data

Open slide detailBeat · SolutionLoop · Jobs To Be Done

The slide contrasts the therapeutic benefit (MADRS) with the lack of side effects (CADSS) compared to S-Ketamine benchmarks.cite_precedent

Open slide detailBeat · SolutionLoop · Jobs To Be Done

CADSS = Clinician administered dissociative states scale. Data points are clustered by time interval.analyze_data

Open slide detailBeat · SolutionLoop · Jobs To Be Done

The slide uses a standard clinical trial flow diagram (randomization to treatment arms).present_framework

Open slide detailBeat · SolutionLoop · Jobs To Be Done

The slide uses a comparison structure to contrast safety/tolerability goals against efficacy goals.present_framework

Open slide detailBeat · SolutionLoop · Jobs To Be Done

front_matter

Open slide detailBeat · SolutionLoop · Jobs To Be Done

summarize

Open slide detailBeat · SolutionLoop · Jobs To Be Done

The chart compares 25mg, 10mg, and 1mg (comparator) dosages. Statistical significance is marked with asterisks.analyze_data

Open slide detailBeat · SolutionLoop · Jobs To Be Done

The slide outlines the study arms, randomization ratios, and primary endpoint timing for two distinct clinical trials.plan_implementation

Open slide detailBeat · SolutionLoop · Jobs To Be Done

The slide uses a list of three key regulatory takeaways followed by a forward-looking implication for the pipeline.summarize

Open slide detailBeat · SolutionLoop · Jobs To Be Done

front_matter

Open slide detailBeat · SolutionLoop · Jobs To Be Done

The slide introduces the drug candidate VLS-01, providing its chemical identity and current clinical trial status.establish_context

Open slide detailBeat · SolutionLoop · Jobs To Be Done

The chart displays statistical significance markers (p-values) at Day 1, Day 2, and Day 7.analyze_data

Open slide detailBeat · SolutionLoop · Jobs To Be Done

The slide uses a process flow diagram to represent clinical trial cohorts and SMG (Safety Monitoring Group) review gates.present_framework

Open slide detailBeat · SolutionLoop · Jobs To Be Done

front_matter

Open slide detailBeat · SolutionLoop · Jobs To Be Done

The chart shows a non-inferiority test using the Hamilton Anxiety Rating Scale (Ham-A).present_solution

Open slide detailBeat · SolutionLoop · Jobs To Be Done

Slide 29 of the presentation.present_framework

Open slide detailBeat · SolutionLoop · Jobs To Be Done

Slide 30. Includes statistical significance markers (*, **, ***).analyze_data

Open slide detailBeat · SolutionLoop · Jobs To Be Done

The slide uses topographical brain maps to visualize EEG data changes. Significant channels are marked with black circles.analyze_data

Open slide detailBeat · SolutionLoop · Jobs To Be Done

Slide 32 of a presentation.summarize

Open slide detailBeat · SolutionLoop · Jobs To Be Done

front_matter

Open slide detailBeat · SolutionLoop · Jobs To Be Done

The slide uses a vertical process flow to show the progression from pre-clinical to clinical phases, mapped against key de-risking milestones.present_solution

Open slide detailBeat · SolutionLoop · Jobs To Be Done

The slide uses a grouped bar chart to show T-scores across three cognitive tests (HVLT, Symbol Coding, Category Fluency) for four dosage groups.analyze_data

Open slide detailBeat · SolutionLoop · Jobs To Be Done

Includes study design diagram and assessment schedule table.present_framework

Open slide detailBeat · SolutionLoop · Jobs To Be Done

front_matter

Open slide detailBeat · SolutionLoop · Jobs To Be Done

The slide uses a chemical structure diagram to establish the scientific basis for the product.present_solution

Open slide detailBeat · SolutionLoop · Jobs To Be Done

The slide outlines two distinct clinical study parts: a Single Ascending Dose (SAD) study and a crossover comparator study.present_framework